Citi raised the firm’s price target on Emerson (EMR) to $133 from $127 and keeps a Buy rating on the shares. Emerson earnings could be more resilient versus investor expectations given the company’s “strong” underlying profitability and “meaningful self-help opportunities,” the analyst tells investors in a research note. Citi views the stock’s recent de-rating as :having gone too far” versus the concerns that are out there given Emerson’s “favorable exposure” to secular long-term tailwinds and the company’s earnings quality. The stock remains a top pick at Citi.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric: Resilient Growth and Profitability Amid Strategic Initiatives and Market Potential
- Sell Recommendation for Emerson Electric Due to Overly Optimistic Growth Projections and Market Concerns
- Emerson price target lowered to $130 from $140 at Baird
- Emerson price target raised to $127 from $119 at Citi
- Emerson price target raised to $104 from $99 at Barclays